Clinical Analysis of Supportive Therapy to Bronchial Asthma with Roxithromycin
YANG Zhiwei. The People’s Hospital of Zengcheng,Guangdong Province 511300
Objective:To observe the anti-inflammation activity of Roxithromycin in treatment of bronchial asthma.Methods:116 cases of bronchial asthma were divided into three groups randomly:treated group A,treated group B and the control group. Medrol was given group A and roxithromyain was given group B as supportive therapy. The symptoms,physical signs,immunity and so on before and after the treatment in the three group were compared.Results: The curative efficary in the two treated groups was obviously higher than that in the control group( P 0.01),and the difference between the two treated groups was not obvious.In the two treated groups,the EOS level after treatment obviously declined copmpared with that before treatment ( P 0.01).The difference of EOS in the two treated groups after therapy was not obvious( P 0.05),while in the control group it was obvious ( P 0.05) before and after therapy. Conclusion:In the treatment of bronchial asthma Roxthromycin and cortin have a similar anti-inflammation activity.